Literature DB >> 18334611

Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo.

Dawn K Coletta1, Bogdan Balas, Alberto O Chavez, Muhammad Baig, Muhammad Abdul-Ghani, Sangeeta R Kashyap, Franco Folli, Devjit Tripathy, Lawrence J Mandarino, John E Cornell, Ralph A Defronzo, Christopher P Jenkinson.   

Abstract

This study was undertaken to test the hypothesis that short-term exposure (4 h) to physiological hyperinsulinemia in normal, healthy subjects without a family history of diabetes would induce a low grade inflammatory response independently of glycemic status. Twelve normal glucose tolerant subjects received a 4-h euglycemic hyperinsulinemic clamp with biopsies of the vastus lateralis muscle. Microarray analysis identified 121 probe sets that were significantly altered in response to physiological hyperinsulinemia while maintaining euglycemia. In normal, healthy human subjects insulin increased the mRNAs of a number of inflammatory genes (CCL2, CXCL2 and THBD) and transcription factors (ATF3, BHLHB2, HES1, KLF10, JUNB, FOS, and FOSB). A number of other genes were upregulated in response to insulin, including RRAD, MT, and SGK. CITED2, a known coactivator of PPARalpha, was significantly downregulated. SGK and CITED2 are located at chromosome 6q23, where we previously detected strong linkage to fasting plasma insulin concentrations. We independently validated the mRNA expression changes in an additional five subjects and closely paralleled the results observed in the original 12 subjects. A saline infusion in healthy, normal glucose-tolerant subjects without family history of diabetes demonstrated that the genes altered during the euglycemic hyperinsulinemic clamp were due to hyperinsulinemia and were unrelated to the biopsy procedure per se. The results of the present study demonstrate that insulin acutely regulates the levels of mRNAs involved in inflammation and transcription and identifies several candidate genes, including HES1 and BHLHB2, for further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334611      PMCID: PMC3581328          DOI: 10.1152/ajpendo.00607.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  44 in total

Review 1.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

Authors:  P R Shepherd; B B Kahn
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

2.  The pathobiology of diabetic complications: a unifying mechanism.

Authors:  Michael Brownlee
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

3.  Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle.

Authors:  Dawn K Richardson; Sangeeta Kashyap; Mandeep Bajaj; Kenneth Cusi; Steven J Mandarino; Jean Finlayson; Ralph A DeFronzo; Christopher P Jenkinson; Lawrence J Mandarino
Journal:  J Biol Chem       Date:  2004-12-14       Impact factor: 5.157

4.  Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers.

Authors:  John J Eady; Gary M Wortley; Yvette M Wormstone; Jackie C Hughes; Siân B Astley; Robert J Foxall; Joanne F Doleman; Ruan M Elliott
Journal:  Physiol Genomics       Date:  2005-07-12       Impact factor: 3.107

5.  Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes.

Authors:  Celena Scheede-Bergdahl; Milena Penkowa; Juan Hidalgo; David B Olsen; Peter Schjerling; Clara Prats; Robert Boushel; Flemming Dela
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

6.  Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.

Authors:  M Pendergrass; J Koval; C Vogt; H Yki-Jarvinen; P Iozzo; R Pipek; H Ardehali; R Printz; D Granner; R A DeFronzo; L J Mandarino
Journal:  Diabetes       Date:  1998-03       Impact factor: 9.461

Review 7.  Insulin signaling in the arterial wall.

Authors:  W A Hsueh; R E Law
Journal:  Am J Cardiol       Date:  1999-07-08       Impact factor: 2.778

8.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

Authors:  M Krssak; K Falk Petersen; A Dresner; L DiPietro; S M Vogel; D L Rothman; M Roden; G I Shulman
Journal:  Diabetologia       Date:  1999-01       Impact factor: 10.122

Review 9.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

10.  Individuality and variation in gene expression patterns in human blood.

Authors:  Adeline R Whitney; Maximilian Diehn; Stephen J Popper; Ash A Alizadeh; Jennifer C Boldrick; David A Relman; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more
  39 in total

1.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo.

Authors:  Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

2.  KLF10 transcription factor regulates hepatic glucose metabolism in mice.

Authors:  Xiaoying Yang; Qi Chen; Lihong Sun; Huabing Zhang; Lu Yao; Xiaona Cui; Yong Gao; Fude Fang; Yongsheng Chang
Journal:  Diabetologia       Date:  2017-08-23       Impact factor: 10.122

3.  Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.

Authors:  Manya Warrier; Terry D Hinds; Kelly J Ledford; Harrison A Cash; Payal R Patel; Thomas A Bowman; Lance A Stechschulte; Weidong Yong; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

Review 4.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

Review 5.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

6.  The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans.

Authors:  Vicencia Sales; Mary-Elizabeth Patti
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-12-09

Review 7.  Functional role of KLF10 in multiple disease processes.

Authors:  Malayannan Subramaniam; John R Hawse; Nalini M Rajamannan; James N Ingle; Thomas C Spelsberg
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

8.  JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy.

Authors:  Anna Raffaello; Giulia Milan; Eva Masiero; Silvia Carnio; Donghoon Lee; Gerolamo Lanfranchi; Alfred Lewis Goldberg; Marco Sandri
Journal:  J Cell Biol       Date:  2010-10-04       Impact factor: 10.539

9.  Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals.

Authors:  Alberto O Chavez; Subhash Kamath; Rucha Jani; Lokendra K Sharma; Adriana Monroy; Muhammad A Abdul-Ghani; Victoria E Centonze; Padma Sathyanarayana; Dawn K Coletta; Cristopher P Jenkinson; Yidong Bai; Franco Folli; Ralph A Defronzo; Devjit Tripathy
Journal:  J Clin Endocrinol Metab       Date:  2009-10-28       Impact factor: 5.958

10.  The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway.

Authors:  Aurélie Granjon; Marie-Paule Gustin; Jennifer Rieusset; Etienne Lefai; Emmanuelle Meugnier; Isabelle Güller; Catherine Cerutti; Christian Paultre; Emmanuel Disse; Rémi Rabasa-Lhoret; Martine Laville; Hubert Vidal; Sophie Rome
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.